Tatva Chintan Pharma Chem Ltd

Tatva Chintan | 543321

Live

₹1,326.50

+₹87.24 (+7.04%)

As on 10/07/26, 4:12 PM

Market Cap2,898.74 CR

Current Price₹1,326.5

High / Low₹1,610 / 919.75

PE Ratio278.26

Book Value₹315.84

Dividend Yield0.15%

ROCE1.19%

ROE0.05%

Face Value₹2.00

Current Vol.1,19,848

Average Vol.---

ISININE0GK401011

PB Ratio2.15

Debt to Equity0.03

Net Profit Margin1.49

Operating Margin9.6

Share Price Chart - Tatva Chintan Pharma Chem Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹1,239.2₹1,253.6

₹1,326.5

Previous CloseToday's Open

₹919.75₹1,610

₹1,326.5

52W Low52W High

₹1,253.6Today's Open

₹1,239.2Previous Close

1,19,848Volume

₹919.7552W Low

₹1,61052W High

Ratios

No data available

About Company

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'
The Company is promoted by Mr
Chintan Nitin Kumar Shah, Mr
Ajay Kumar Mansukhlal Patel and Mr
Shekhar Rasiklal Somani
The Company is a globally recognized specialty chemical player with several market leading products in its portfolio
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i
, Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC)
These products cater to diverse industries such as pharmaceuticals, agrochemicals, automotive, electronics, resins and polymers, flavours and fragrances, personal care and disinfectants, oil field and energy storage

Ethics: Tatva Chintan Pharma Chem Ltd is flagged for

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI54.27

SMA 201204.68

SMA 501226.47

SMA 1001207.82

SMA 2001256.79

SMA 101219.38

MACD_12_26_Days7.17

EMA10Day1220.57

EMA20Day1212.12

EMA50Day1213.19

MACD_12_26_9_Days4.85

EMA100Day1218.80

EMA200Day1198.32

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth-2.74%

ROE0.77%

EBITDA Margin9.60%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	382.71	393.50	423.61	433.65	300.36
Interest	1.29	6.53	8.40	4.83	4.21
Expenses	348.50	325.31	363.03	325.41	233.92
Financing Profit	36.53	75.70	66.32	117.13	71.64
Financing Margin %	10%	19%	16%	27%	24%
Other Income	2.32	7.51	5.74	8.89	5.20
Depreciation	27.66	25.61	9.56	8.18	6.73
Profit before tax	7.58	43.57	44.78	104.12	60.70
Tax %	25%	30%	-2%	8%	14%
Net Profit	5.71	30.35	45.49	95.87	52.26
EPS in Rs	2.44	13.26	20.52	44.59	26.02

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

26 Sept 2025

AGM

26 Aug 2025

12 Sept 2025

Final Dividend (₹1)

Outcome of Board Meeting - Board approves Dividend The Board Recommended a Final Dividend of Rs. 1/- (10%) per equity share of Rs. 10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs. 23,39,20,550/- (2,33,92,055 equity shares of Rs. 10/- each) for the financial year 2024-25. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company

02 May 2025

20 Sept 2024

AGM

27 Aug 2024

07 Sept 2024

Final Dividend (₹2)

Board Meeting Outcome for Outcome Of The Board Meeting Held On 03.05.2024 The Board Recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs. 23,39,20,550/- (2,33,92,055 equity shares of Rs. 10/- each) for the financial year 2023-24. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.

03 May 2024

22 Sept 2023

AGM

18 Aug 2023

08 Sept 2023

Final Dividend (₹2)

Outcome Of The Board Meeting Held On 05.05.2023 Intimation of Record date, Book Closure and Cut-off date pursuant to Regulation 42 and 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) (As Per BSE Announcement dated on 26.08.2023)

05 May 2023

22 Sept 2022

AGM

23 Aug 2022

09 Sept 2022

Final Dividend (₹2)

The Board Recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs. 22,16,50,620/- (2,21,65,062 equity shares of Rs. 10/- each) for the financial year 2021-22. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.

25 Apr 2022

29 Sept 2021

AGM

06 Sept 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
1,240	2,901	69	4	37	0	1.49%
1,591	1,61,974	66	15	57	0	16.92%
2,751	81,560	43	6	30	0	11.62%
6,995	59,656	109	14	76	0	18.30%
3,867	42,476	72	5	44	0	11.52%
1,217	40,986	32	4	23	4	8.42%
7,696	39,476	59	10	48	1	12.28%
650	32,790	44	7	40	0	16.20%
1,623	22,140	40	4	28	0	8.42%
1,488	19,743	87	8	67	0	18.88%

Showing 10 of 136 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Tatva Chintan Pharma Chem Ltd?

The current share price of Tatva Chintan Pharma Chem Ltd (Tatva Chintan) is ₹1326.50. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Tatva Chintan Pharma Chem Ltd?

The Price-to-Earnings (P/E) ratio of Tatva Chintan Pharma Chem Ltd is 1326.50. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Tatva Chintan Pharma Chem Ltd?

Tatva Chintan Pharma Chem Ltd has a 52-week high of ₹1610.00 and a 52-week low of ₹919.75. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Tatva Chintan Pharma Chem Ltd?

Tatva Chintan Pharma Chem Ltd offers a dividend yield of 0.16%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Tatva Chintan Pharma Chem Ltd?

The Earnings Per Share (EPS) of Tatva Chintan Pharma Chem Ltd is ₹17.98. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Tatva Chintan Pharma Chem Ltd?

Tatva Chintan Pharma Chem Ltd has a Return on Equity (ROE) of 0.05%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video